Literature DB >> 12425863

Incidence and prevalence of overactive bladder.

Eric S Rovner1, Alan J Wein.   

Abstract

Recent changes in terminology, diagnosis, and therapy have refocused attention on overactive bladder (OAB). This symptom syndrome is highly prevalent worldwide and significantly impairs the quality of life of those who suffer from it. Accurate epidemiologic incidence and prevalence studies of OAB have been hampered in the past by, among other issues, a generalized lack of agreement regarding definition of the disorder, and consequently, accurate case finding. This obstacle resulted in considerably wide estimates in the reported incidence and prevalence of OAB in the literature. A new symptom-based definition of OAB, formally adopted by the Standardization Committee at a recent International Continence Society meeting, should provide a framework for future epidemiologic studies. Current estimates of incidence, prevalence, effects on quality of life, and societal costs may need to be reassessed based on these new data.

Entities:  

Mesh:

Year:  2002        PMID: 12425863     DOI: 10.1007/s11934-002-0093-5

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   2.862


  9 in total

1.  Overactive bladder: defining the disease.

Authors:  A J Wein
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

2.  The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.

Authors:  Paul Abrams; Linda Cardozo; Magnus Fall; Derek Griffiths; Peter Rosier; Ulf Ulmsten; Philip van Kerrebroeck; Arne Victor; Alan Wein
Journal:  Neurourol Urodyn       Date:  2002       Impact factor: 2.696

Review 3.  The Overactive Bladder: From Basic Science to Clinical Management Consensus Conference. Proceedings. London, England, June 29, 1997.

Authors: 
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

4.  Overactive bladder.

Authors:  C K Payne
Journal:  Urology       Date:  1998-06       Impact factor: 2.649

5.  How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.

Authors:  I Milsom; P Abrams; L Cardozo; R G Roberts; J Thüroff; A J Wein
Journal:  BJU Int       Date:  2001-06       Impact factor: 5.588

Review 6.  Epidemiology, pathophysiology, and evaluation of urinary incontinence and overactive bladder.

Authors:  C K Payne
Journal:  Urology       Date:  1998-02       Impact factor: 2.649

Review 7.  The prevalence of overactive bladder.

Authors:  I Milsom; W Stewart; J Thüroff
Journal:  Am J Manag Care       Date:  2000-07       Impact factor: 2.229

Review 8.  Diagnosis and significance of idiopathic overactive bladder.

Authors:  W Artibani
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

9.  Definition of overactive bladder and epidemiology of urinary incontinence.

Authors:  C Hampel; D Wienhold; N Benken; C Eggersmann; J W Thüroff
Journal:  Urology       Date:  1997-12       Impact factor: 2.649

  9 in total
  5 in total

Review 1.  The bladder-brain connection: putative role of corticotropin-releasing factor.

Authors:  Rita J Valentino; Susan K Wood; Alan J Wein; Stephen A Zderic
Journal:  Nat Rev Urol       Date:  2010-12-07       Impact factor: 14.432

2.  Social stress-induced bladder dysfunction: potential role of corticotropin-releasing factor.

Authors:  Susan K Wood; Madelyn A Baez; Seema Bhatnagar; Rita J Valentino
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-03-11       Impact factor: 3.619

3.  Impact of overactive bladder on the brain: central sequelae of a visceral pathology.

Authors:  Elizabeth Rickenbacher; Madelyn A Baez; Lyman Hale; Steven C Leiser; Stephen A Zderic; Rita J Valentino
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-21       Impact factor: 11.205

Review 4.  Preview of new drugs for overactive bladder and incontinence: darifenacin, solifenacin, trospium, and duloxetine.

Authors:  Richard T Kershen; Mike Hsieh
Journal:  Curr Urol Rep       Date:  2004-10       Impact factor: 2.862

5.  A comparison of the efficacy of darifenacin alone vs. darifenacin plus a Behavioural Modification Programme upon the symptoms of overactive bladder.

Authors:  M B Chancellor; F Kianifard; E Beamer; L Mongay; U Ebinger; G Hicks; A Delconte
Journal:  Int J Clin Pract       Date:  2008-04       Impact factor: 2.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.